Cosmos Health Inc. disclosed on February 19 2026 that independent valuation reports estimate the fair market value of its wholly owned real‑estate portfolio—Cana Laboratories in Athens and the CosmoFarm logistics center in Peristeri—at approximately $15 million. The valuation covers land and building value only, excluding machinery and equipment housed within the facilities.
The $15 million estimate exceeds Cosmos Health’s market capitalization of $13.5 million (as of February 17 2026) and highlights a substantial discount to book value, where the company’s book value per share was $2.01 while the share price was $0.72. The valuation therefore represents a potential liquidity source if the assets are monetized, offering a tangible asset base that could be leveraged to address the company’s liquidity constraints and support its vertically integrated healthcare model.
Management indicated that the valuation supports strategic options such as an outright sale, joint‑venture structures, or sale‑leaseback transactions. These options could reduce debt or fund core operations, aligning with the company’s goal of improving its financial position while maintaining operational control of its manufacturing and distribution facilities.
Cosmos Health’s financial health context underscores the importance of the valuation. The company reported a negative operating margin of –28.6 % and a net margin of –31.01 % as of February 19 2026, with a current ratio of 0.99 and a high debt‑to‑equity ratio (reported as 91.1× in one source and 0.91 in another). The Greek property market is favorable, driven by strong rental yields and demand, which supports the valuation’s upside potential.
The valuation’s alignment with the company’s asset‑heavy, vertically integrated model suggests that monetizing the real‑estate portfolio could unlock value and provide the capital needed to address debt and liquidity challenges, while preserving the operational footprint that underpins Cosmos Health’s core business.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.